June 9, 2023 Comments Off on New patent for Glaxo Grp drug BREO ELLIPTA Posted in: Patent Added Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are…
The post New patent for Glaxo Grp drug BREO ELLIPTA appeared first on DrugPatent…
June 9, 2023 Comments Off on Which pharmaceutical companies have the most SPCs in Norway? Posted in: Infographic This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Norway. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical …